Table 1.
Demographics and clinical data.
| Demographics | Clinical Data | OFF-medication | ON-medication | p-Value | pFDR |
|---|---|---|---|---|
| Sample size | 15 | |||
| Age, yrs | 62.00 (10.51) | |||
| Gender (M | F) | 9 | 6 | |||
| Disease duration, yrs | 5.17 (4.78) | |||
| Hoehn and Yahr stage (OFF-med) | 1.67 (0.62) | |||
| Total LEDD | 674.00 (364.59) | |||
| MDS-UPDRS-III – Total | 16.80 (8.51) | 13.13 (6.98) | < 0.001 | < 0.001 |
| MoCA | 27.20 (2.18) | 27.67 (1.54) | 0.301 | 0.597 |
Data are count or mean (± SD) (n = 15). Disease duration is defined as time since diagnosis. p-Values are uncorrected. pFDR values are FDR corrected. Abbreviations: F = females; LEDD = levodopa equivalent daily dose; M = males; MoCA = Montreal Cognitive Assessment; MDS-UPDRS-III = the motor section of the Movement Disorder Society Unified Parkinson's Disease Rating Scale.